Not Yet RecruitingNCT04003285
Allopregnanolone or placebo for depression and pain after mild brain injury
About this title
Read the official source — NCT04003285Medication studyAges 21–62United States
Understand this study
Who could participate?
Listed age limits: 21 years to 62 years.
- Listed locations
- DurhamSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: December 1, 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 132
- Sponsor
- VA Office of Research and Development
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 62 Years
- Official registry ID
- NCT04003285
- Official title
Show the full official title
Novel Regenerative Therapeutic in Chronic Complex TBI
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Durham
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is VA Office of Research and Development, a government agency.
Does this study involve medication?
Yes. The study involves medication, including Placebo and Allopregnanolone.
Who can participate?
Listed age limits: 21 years to 62 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
